title: Response to comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'.
authors.affiliation: 1] Department of Oncology, Vejle Hospital, Vejle, Denmark [2] Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, 7100 Vejle, Denmark.
authors.forename: K-L G
authors.initials: KL
authors.lastname: Spindler
authors.affiliation: 1] Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, 7100 Vejle, Denmark [2] Department of Biochemistry, Vejle Hospital, Vejle, Denmark.
authors.forename: N
authors.initials: N
authors.lastname: Pallisgaard
authors.affiliation: 1] Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, 7100 Vejle, Denmark [2] Department of Biochemistry, Vejle Hospital, Vejle, Denmark.
authors.forename: R F
authors.initials: RF
authors.lastname: Andersen
authors.affiliation: 1] Department of Oncology, Vejle Hospital, Vejle, Denmark [2] Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, 7100 Vejle, Denmark.
authors.forename: A
authors.initials: A
authors.lastname: Jakobsen
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000188:drug therapy*; D004273:DNA, Neoplasm / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D011518:Proto-Oncogene Proteins / Q000097:blood* / Q000235:genetics*; D018631:ras Proteins / Q000097:blood* / Q000235:genetics*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004273:DNA, Neoplasm; D011518:Proto-Oncogene Proteins; D018631:ras Proteins; D002166:Camptothecin